Terms: = Breast cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Clinical Outcome
20 results:
1. Potential role of cxcr4 in trastuzumab resistance in breast cancer patients.
Kotb RM; Ibrahim SS; Mostafa OM; Shahin NN
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166520. PubMed ID: 35985446
[TBL] [Abstract] [Full Text] [Related]
2. Mouse Modeling Dissecting Macrophage-breast cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and breast Tumorigenesis.
Müller AK; Köhler UA; Trzebanski S; Vinik Y; Raj HM; Girault JA; Ben-Chetrit N; Maraver A; Jung S; Lev S
Adv Sci (Weinh); 2022 Mar; 9(9):e2105696. PubMed ID: 35092356
[TBL] [Abstract] [Full Text] [Related]
3. cxcr4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5.
Nengroo MA; Maheshwari S; Singh A; Verma A; Arya RK; Chaturvedi P; Saini KK; Singh AK; Sinha A; Meena S; Gupta A; Mishra A; Sarkar J; Datta D
Cell Death Dis; 2021 May; 12(5):464. PubMed ID: 33966046
[TBL] [Abstract] [Full Text] [Related]
4. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 breast cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract] [Full Text] [Related]
5. breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-cxcr4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract] [Full Text] [Related]
6. Heregulin/ErbB3 Signaling Enhances cxcr4-Driven Rac1 Activation and breast cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract] [Full Text] [Related]
7. Expression patterns of SDF1/cxcr4 in human invasive breast carcinoma and adjacent normal stroma: correlation with tumor clinicopathological parameters and patient survival.
Papatheodorou H; Papanastasiou AD; Sirinian C; Scopa C; Kalofonos HP; Leotsinidis M; Papadaki H
Pathol Res Pract; 2014 Oct; 210(10):662-7. PubMed ID: 25041836
[TBL] [Abstract] [Full Text] [Related]
8. CXCL12-cxcr4 axis promotes the natural selection of breast cancer cell metastasis.
Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
[TBL] [Abstract] [Full Text] [Related]
9. High level of cxcr4 in triple-negative breast cancer specimens associated with a poor clinical outcome.
Yu S; Wang X; Liu G; Zhu X; Chen Y
Acta Med Okayama; 2013; 67(6):369-75. PubMed ID: 24356721
[TBL] [Abstract] [Full Text] [Related]
10. Aberrant expression of cxcr4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Yang P; Liang SX; Huang WH; Zhang HW; Li XL; Xie LH; Du CW; Zhang GJ
Curr Mol Med; 2014 Jan; 14(1):174-84. PubMed ID: 24256053
[TBL] [Abstract] [Full Text] [Related]
11. Src and cxcr4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib.
De Luca A; D'Alessio A; Gallo M; Maiello MR; Bode AM; Normanno N
Cell Cycle; 2014; 13(1):148-56. PubMed ID: 24200972
[TBL] [Abstract] [Full Text] [Related]
12. The molecular and clinicopathologic characteristics of bilateral breast cancer.
Chen SF; Du CW; Yang P; Zhang HW; Kwan M; Zhang GJ
Sci Rep; 2013; 3():2590. PubMed ID: 24005135
[TBL] [Abstract] [Full Text] [Related]
13. The impact of chemokine receptor cxcr4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract] [Full Text] [Related]
14. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
[TBL] [Abstract] [Full Text] [Related]
15. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract] [Full Text] [Related]
16. Differential expression of arrestins is a predictor of breast cancer progression and survival.
Michal AM; Peck AR; Tran TH; Liu C; Rimm DL; Rui H; Benovic JL
Breast Cancer Res Treat; 2011 Dec; 130(3):791-807. PubMed ID: 21318602
[TBL] [Abstract] [Full Text] [Related]
17. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract] [Full Text] [Related]
18. High chemokine receptor cxcr4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
[TBL] [Abstract] [Full Text] [Related]
19. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Dimberg J; Hugander A; Löfgren S; Wågsäter D
Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
[TBL] [Abstract] [Full Text] [Related]
20. The elevated level of cxcr4 is correlated with nodal metastasis of human breast cancer.
Kang H; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
Breast; 2005 Oct; 14(5):360-7. PubMed ID: 16216737
[TBL] [Abstract] [Full Text] [Related]
